BioSpace News Archive

SANTA CLARA, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Promex Industries , a biotech microelectronics manufacturer specializing in heterogeneous integration of key subsystems for medical, diagnostic and life sciences devices, announced it will exhibit at the 35 th annual Medical Design & Manufacturing (MD&M) West conference and exposition in Anaheim, February 11-13. Focused on medical device and life science programs, Promex will showcase its proven capabilities for taking developm

Myndshft Technologies, a leading provider of real-time medical and pharmacy benefit check technology today announced that it will sponsor the upcoming Diagnostic Coverage & Reimbursement Conference, February 11-12 in San Diego.

HealthLynked Corp. (OTCQB: HLYK), a nationwide healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients and medical data today announced that to help its members keep track of the deadly corona virus epidemic, it has provided a GEO tracker of cases rep

The Campbell Institute at the National Safety Council is proud to announce six new member organizations dedicated to world class environment, health and safety practices.

Feb. 5, 2020 15:00 UTC -- VYONDYS 53™ is the second RNA exon-skipping treatment for DMD approved in the U.S. -- -- Orsini Pharmaceutical Services is a select dispensing pharmacy for Sarepta’s DMD products EXONDYS 51® (eteplirsen) and VYONDYS 53™ (golodirsen) --

PharmaJet®, the maker of innovative, needle-free injection technology, today announced the publication of independent survey results from the first large-scale campaign using its needle-free technology.

Quartesian , a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today announced its 17th consecutive year of increased contract bookings and record revenue for 2019. “Our clinical data-focused solution strategy continues to ga

The Biologic Association will hold their 1 st Summit Feb. 5-8 in Carlsbad, California that will provide an interactive environment for all orthobiologics stakeholders to discover, learn, exchange and collaborate new ideas and thought processes on a variety of novel biologic therapies.

Takeda continues to gather and apply real-world evidence to improve the diagnosis of hemophilia and advance personalized treatment in its ongoing commitment to ensuring people living with bleeding disorders receive the most effective care possible

Bedford Campus Adds to Commercial Capacity with High-Speed Fill Line and Large-Scale Freeze-Dryers